AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2020
Jan 9, 2020
34931_dirs_2020-01-09_58ed7718-c211-43db-a0a1-e6b2fdb6f206.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2020-01-08
Reporting Person: Mazzo David J (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-08 | Common Stock | F | 4522 | $2.83 | Disposed | 153010 | Direct |
Footnotes
F1: Includes 43,575 unvested restricted stock.